Literature DB >> 21572038

Transautocrine signaling by membrane neuregulins requires cell surface targeting, which is controlled by multiple domains.

Juan Carlos Montero1, Ruth Rodríguez-Barrueco, Atanasio Pandiella.   

Abstract

The neuregulins (NRGs) play important roles in animal development and homeostasis, and their deregulation has been linked to diseases such as cancer and schizophrenia. The NRGs belong to the epidermal growth factor (EGF) family of transmembrane growth factors. Although NRGs may be synthesized as transmembrane proteins (the pro-NRGs), some of them lack an N-terminal signal sequence, raising the question of how these pro-NRGs are directed to the plasma membrane. Here we have explored the domains of pro-NRGs that are required for their membrane anchoring, cell surface exposure, and biological activity. We show that an internal hydrophobic region acts as a membrane-anchoring domain, but other regions of pro-NRG are required for proper sorting to the plasma membrane. Using mutants that are located in different subcellular compartments, we show that only plasma membrane-exposed pro-NRG is biologically active. At this location, the pro-NRGs may act as transautocrine molecules (i.e. as membrane factors able to activate receptors present in cells that are in physical contact with the pro-NRG-producing cells (in trans) or capable of activating receptors present in the pro-NRG-producing cells (in cis)).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572038      PMCID: PMC3129214          DOI: 10.1074/jbc.M110.190835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4.

Authors:  D Zhang; M X Sliwkowski; M Mark; G Frantz; R Akita; Y Sun; K Hillan; C Crowley; J Brush; P J Godowski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Structural and functional aspects of the multiplicity of Neu differentiation factors.

Authors:  D Wen; S V Suggs; D Karunagaran; N Liu; R L Cupples; Y Luo; A M Janssen; N Ben-Baruch; D B Trollinger; V L Jacobsen
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

3.  Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail.

Authors:  X Liu; H Hwang; L Cao; M Buckland; A Cunningham; J Chen; K R Chien; R M Graham; M Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 4.  Neuregulins in development.

Authors:  G Lemke
Journal:  Mol Cell Neurosci       Date:  1996-04       Impact factor: 4.314

5.  NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.

Authors:  I M Krane; P Leder
Journal:  Oncogene       Date:  1996-04-18       Impact factor: 9.867

6.  Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.

Authors:  K L Carraway; J L Weber; M J Unger; J Ledesma; N Yu; M Gassmann; C Lai
Journal:  Nature       Date:  1997-05-29       Impact factor: 49.962

7.  Biosynthetic processing of neu differentiation factor. Glycosylation trafficking, and regulated cleavage from the cell surface.

Authors:  T L Burgess; S L Ross; Y X Qian; D Brankow; S Hu
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

8.  The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system.

Authors:  S Britsch; L Li; S Kirchhoff; F Theuring; V Brinkmann; C Birchmeier; D Riethmacher
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

9.  TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment.

Authors:  N Cabrera; E Díaz-Rodríguez; E Becker; D Martín-Zanca; A Pandiella
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

10.  Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization.

Authors:  H S Wiley; M F Woolf; L K Opresko; P M Burke; B Will; J R Morgan; D A Lauffenburger
Journal:  J Cell Biol       Date:  1998-11-30       Impact factor: 10.539

View more
  4 in total

1.  Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.

Authors:  Lin Yang; Travis Vander Steen; Ingrid Espinoza; Elisabet Cuyàs; Sara Verdura; Javier A Menendez; Ruth Lupu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  The immunoglobulin-like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation.

Authors:  Ariana Centa; Ruth Rodríguez-Barrueco; Juan Carlos Montero; Atanasio Pandiella
Journal:  Mol Oncol       Date:  2018-05-14       Impact factor: 6.603

3.  Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma.

Authors:  Sara García-Alonso; Inés Romero-Pérez; Lucía Gandullo-Sánchez; Luis Chinchilla; Alberto Ocaña; Juan Carlos Montero; Atanasio Pandiella
Journal:  J Exp Clin Cancer Res       Date:  2021-08-16

Review 4.  Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders.

Authors:  Liang Shi; Clare M Bergson
Journal:  Transl Psychiatry       Date:  2020-06-16       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.